UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027168
Receipt number R000031131
Scientific Title Impact of a 12-week non-energy-restricted diet with n-3 fatty acid supplementation and moderate physical activity on biochemical parameters, body composition, and physical fitness in women with pre-obesity. Three-arm randomised trial.
Date of disclosure of the study information 2017/04/27
Last modified on 2017/04/27 18:15:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Impact of a 12-week non-energy-restricted diet with n-3 fatty acid supplementation and moderate physical activity on biochemical parameters, body composition, and physical fitness in women with pre-obesity. Three-arm randomised trial.

Acronym

N-3 fatty acid supplementation in combination with life style modification

Scientific Title

Impact of a 12-week non-energy-restricted diet with n-3 fatty acid supplementation and moderate physical activity on biochemical parameters, body composition, and physical fitness in women with pre-obesity. Three-arm randomised trial.

Scientific Title:Acronym

N-3 fatty acid supplementation in combination with life style modification

Region

Europe


Condition

Condition

overweight women

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We sought to examine whether eicosapentaenoic and docosahexaenoic acid supplementation at a relatively low dose of ~0.6 g/day, could modulate the effects of life style modification (iso-caloric diet and moderate physical activity) in healthy women with pre-obesity. The major goal of the study was to characterize the effect of the combined intervention on modulation of adipose tissue function.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Body weight, Body Mass Index, waist circumference, bioelectrical impedance analysis, spiroergometry (VO2 max.), 24-hours dietary recall, adiponectin, leptin, insulin, follistatin, brain-derived neurotrophic factor, leukocyte inhibitory factor, tumor necrosis factor alpha, interleukin 6, interleukin 8, vitamin D.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Food Behavior,custom Other

Interventions/Control_1

Lifestyle modification (in intervened groups: a) with lifestyle modification and b)group with lifestyle modification and n-3 fatty acids supplementation): Lifestyle modification consisted of a 3-month complex "self-tailored" program of defined and supervised physical activity and diet. Physical activity included 30 minutes of continuous walking from the total minimum amount of 10.000 steps a day (monitored by pedometers) and twice a week 1.5 hour of driven and continuously monitored physical activity, where part of aerobic activity respected the initial physical fitness, measured by spiroergometry, continued to grow and was directed according to Karvonen`s heart rate reserve method and Borg scale of subjective perception of the intensity of the load in the aerobic zone load (50-75 % of their individual VO2R) for 45 minutes on training simulators. Personalized diet recommendations were developed on the basis of energy expenditure assessment in combination with habitual caloric intake assessment. Dietary counselling was individualized for each person and participants were encouraged not to reduce caloric intake under the habitual amount, but rather to increase intake of vegetables, fruits, legumes, seeds, nuts and fiber rich complex carbohydrates, vegetable oils with monounsaturated fatty acids, fish and low fat dairy products; and decrease intake of saturated and trans fat, salt, sugars, and red meat. They were instructed to limit intake of vegetable oils with polyunsaturated n-6 fatty acids, and exclude highly processed food from the diet as much as possible. Based on recommended energy content, the participants obtained framework diet plans and were initially educated and checked every week in required diet by dieticians. Control group: No lifestyle modification.

Interventions/Control_2

Supplementation with n-3 polyunsaturated fatty acids (in intervened group with lifestyle modification and n-3 polyunsaturated fatty acids supplementation): eicosapentaenoic and docosahexaenoic acid supplementation at a dose of ~0.6 g per day for 3 months. Control group and group with lifestyle modification: corn oil supplementation.

Interventions/Control_3

Group with placebo: corn oil supplementation without lifestyle modification.

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >=

Gender

Female

Key inclusion criteria

20-60 years of age, women, fulfilling two of three criteria for pre-obesity (overweight), that is Body Mass Index (BMI) in the range of 25-29.9 kgm-2, waist circumference equal or higher than 80 cm, body fat measured by bioelectrical impedance analysis (BIA) equal or higher than 25 percent of total body weight. Ability and willingness to adhere to the protocol and signed and dated written informed consent obtained before the study

Key exclusion criteria

pregnancy and lactation, smoking, long-term medication, history of cardiovascular, endocrine, and metabolic diseases, cancer, significant recent weight gain or loss (more than 5 percent of total body weight within the past 3 months)

Target sample size

34


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Pavel Sedlacek M.D.

Organization

Faculty of Medicine in Pilsen, Charles University, Czech Republic

Division name

Department of Public Health and Preventive Medicine

Zip code


Address

Lidicka 4, 301 66 Pilsen, Czech Republic

TEL

00420377593195

Email

pavel.sedlacek@lfp.cuni.cz


Public contact

Name of contact person

1st name
Middle name
Last name Associate Professor Dana Mullerova M.D., Ph.D.

Organization

Faculty of Medicine in Pilsen, Charles University, Czech Republic

Division name

Department of Public Health and Preventive Medicine

Zip code


Address

Lidicka 4, 301 66 Pilsen, Czech Republic

TEL

00420377593191

Homepage URL

http://www.lfp.cuni.cz/oddeleni/29-ustav-hygieny-a-preventivni-mediciny.html

Email

dana.mullerova@lfp.cuni.cz


Sponsor or person

Institute

Charles University, Czech Republic

Institute

Department

Personal name



Funding Source

Organization

Charles University, Czech Republic

Organization

Division

Category of Funding Organization

Outside Japan

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 04 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 03 Month 06 Day

Date of IRB


Anticipated trial start date

2014 Year 03 Month 10 Day

Last follow-up date

2014 Year 06 Month 08 Day

Date of closure to data entry

2014 Year 06 Month 13 Day

Date trial data considered complete

2014 Year 06 Month 13 Day

Date analysis concluded

2016 Year 06 Month 30 Day


Other

Other related information



Management information

Registered date

2017 Year 04 Month 27 Day

Last modified on

2017 Year 04 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031131


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name